François Bertucci, Steven Van Laere, Daniel Birnbaum
{"title":"炎性乳腺癌的基因组图谱确定了潜在的可操作的基因改变。","authors":"François Bertucci, Steven Van Laere, Daniel Birnbaum","doi":"10.18632/oncoscience.515","DOIUrl":null,"url":null,"abstract":"François Bertucci1,2, Steven Van Laere3, Daniel Birnbaum1 1 Laboratoire d’Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, F-13009, France 2 Département d’Oncologie Médicale, Institut Paoli-Calmettes, Marseille, France 3 Department of Oncological Research, GZA Hospitals Sint-Augustinus, Antwerp, Belgium","PeriodicalId":19508,"journal":{"name":"Oncoscience","volume":"7 7-8","pages":"57-59"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458333/pdf/","citationCount":"1","resultStr":"{\"title\":\"Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations.\",\"authors\":\"François Bertucci, Steven Van Laere, Daniel Birnbaum\",\"doi\":\"10.18632/oncoscience.515\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"François Bertucci1,2, Steven Van Laere3, Daniel Birnbaum1 1 Laboratoire d’Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, F-13009, France 2 Département d’Oncologie Médicale, Institut Paoli-Calmettes, Marseille, France 3 Department of Oncological Research, GZA Hospitals Sint-Augustinus, Antwerp, Belgium\",\"PeriodicalId\":19508,\"journal\":{\"name\":\"Oncoscience\",\"volume\":\"7 7-8\",\"pages\":\"57-59\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458333/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncoscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18632/oncoscience.515\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncoscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18632/oncoscience.515","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations.
François Bertucci1,2, Steven Van Laere3, Daniel Birnbaum1 1 Laboratoire d’Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, F-13009, France 2 Département d’Oncologie Médicale, Institut Paoli-Calmettes, Marseille, France 3 Department of Oncological Research, GZA Hospitals Sint-Augustinus, Antwerp, Belgium
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
